Northwest Bancshares, Inc. Bristol Myers Squibb CO Transaction History

Northwest Bancshares, Inc.

$585 Million
Q3 2024

A detailed history of Northwest Bancshares, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Northwest Bancshares, Inc. holds 4,375 shares of BMY stock, worth $257,162. This represents 0.04% of its overall portfolio holdings.

Number of Shares

4,375

Previous 5,050 13.37%

Holding current value

$257,162

Previous $209,000 8.13%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$39.66 - $51.75 $26,770 - $34,931	-675 Reduced 13.37%	4,375 $226,000
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $34,663 - $41,362	-715 Reduced 12.4%	5,050 $259,000
Q3 2023 Oct 27, 2023	BUY	$57.89 - $64.73 $61,652 - $68,937	1,065 Added 22.66%	5,765 $334,000
Q2 2023 Jul 24, 2023	SELL	$63.71 - $70.74 $11,786 - $13,086	-185 Reduced 3.79%	4,700 $300,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $102,035 - $120,824	-1,490 Reduced 23.37%	4,885 $351,000
Q3 2022 Nov 15, 2022	SELL	$0.13 - $76.84 $1,347 - $796,600	-10,367 Reduced 61.92%	6,375 $454,000
Q2 2022 Aug 16, 2022	SELL	$72.62 - $79.98 $112,996 - $124,448	-1,556 Reduced 8.5%	16,742 $1.29 Million
Q1 2022 Apr 29, 2022	SELL	$61.48 - $73.72 $4.62 Million - $5.54 Million	-75,132 Reduced 80.42%	18,298 $1.34 Million
Q4 2021 Feb 09, 2022	BUY	$53.63 - $62.52 $196,124 - $228,635	3,657 Added 4.07%	93,430 $5.83 Million
Q3 2021 Oct 13, 2021	SELL	$59.17 - $69.31 $295 - $346	-5 Reduced 0.01%	89,773 $5.31 Million
Q2 2021 Aug 06, 2021	SELL	$61.91 - $67.42 $43,708 - $47,598	-706 Reduced 0.78%	89,778 $6 Million
Q1 2021 Apr 23, 2021	BUY	$59.34 - $66.74 $344,172 - $387,091	5,800 Added 6.85%	90,484 $5.71 Million
Q4 2020 Feb 05, 2021	BUY	$57.74 - $65.43 $408,337 - $462,720	7,072 Added 9.11%	84,684 $5.25 Million
Q3 2020 Oct 20, 2020	BUY	$57.43 - $63.64 $400,918 - $444,270	6,981 Added 9.88%	77,612 $4.68 Million
Q2 2020 Aug 07, 2020	BUY	$54.82 - $64.09 $297,782 - $348,136	5,432 Added 8.33%	70,631 $4.15 Million
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $33,825 - $49,156	-729 Reduced 1.11%	65,199 $3.63 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $2.27 Million - $2.96 Million	46,190 Added 234.02%	65,928 $4.23 Million
Q3 2019 Oct 09, 2019	SELL	$42.77 - $50.71 $37,894 - $44,929	-886 Reduced 4.3%	19,738 $1 Million
Q2 2019 Jul 17, 2019	BUY	$44.62 - $49.34 $22,622 - $25,015	507 Added 2.52%	20,624 $935,000
Q1 2019 Apr 24, 2019	SELL	$45.12 - $53.8 $13,536 - $16,140	-300 Reduced 1.47%	20,117 $960,000
Q4 2018 Feb 08, 2019	SELL	$48.76 - $63.23 $14,628 - $18,969	-300 Reduced 1.45%	20,417 $1.06 Million
Q3 2018 Oct 02, 2018	BUY	$55.19 - $62.25 $96,858 - $109,248	1,755 Added 9.26%	20,717 $1.29 Million
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $3,295 - $3,793	-55 Reduced 0.29%	18,962 $1.2 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $1.14 Million - $1.24 Million	19,017	19,017 $1.17 Million

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwest Bancshares, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Northwest Bancshares, Inc. with notifications on news.

Account

Northwest Bancshares, Inc. Bristol Myers Squibb CO Transaction History